Workplace Drug Testing Service

BizBite Deep Dive — Workplace Drug Testing Services

1) Executive Summary (5 bullets)

• Workplace drug testing is a boring B2B compliance business: employers pay because safety rules, insurance requirements, DOT programs, hiring workflows, and post-accident procedures force repeat demand.
• The acquisition target is not a lab science startup. It is usually a local clinic, collection site, mobile collector, or third-party administrator with employer accounts, clean chain-of-custody process, and lab/MRO relationships.
• Best buyer thesis: buy a subscale operator at 3.0x-4.5x SDE, tighten scheduling and documentation, add mobile collections, and cross-sell background checks, physicals, and DOT consortium management.
• Main risks are documentation errors, account concentration, state-by-state drug policy changes, weak collector training, slow lab turnaround, and owner-dependent employer relationships.
• Underwriting target: 20-30% EBITDA/SDE margin after paying replacement labor, less than 20% revenue from the top customer, documented recurring employer accounts, and at least 1.25x post-debt service coverage under conservative volume assumptions.

2) Market Research (TAM/SAM/SOM-style reasoning)

What the market is

• Services sold: pre-employment screens, random testing, post-accident testing, reasonable-suspicion testing, return-to-duty programs, DOT consortium administration, alcohol breath tests, mobile/on-site collections, and policy support.
• Core buyers: trucking fleets, logistics operators, construction companies, staffing agencies, manufacturers, schools, municipalities, healthcare employers, energy/utility contractors, and any employer with safety-sensitive roles.
• Demand trigger is operational risk, not fashion. A failed audit, workplace accident, insurance requirement, or hiring backlog creates urgency.

TAM

• Grand View Research estimated the U.S. employer and workplace drug testing market at about $2.57B in 2024, with a path toward roughly $4.01B by 2033 at about 5.2% CAGR.
• Broader U.S. drug-of-abuse testing services estimates around $1B+ reinforce that this is a real services market, not a tiny niche.
• TAM includes national labs and big occupational-health platforms, so a local acquisition buyer should not pretend all TAM is reachable.

SAM

• For one metro operator, the practical SAM is employers within 30-60 minutes that need recurring testing or fast local collection.
• Example metro math: 2,000 target employers x 35 covered employees average x 1.2 tests per covered employee per year x $55 blended gross collection/testing revenue = about $4.6M local annual testing spend.
• Narrower compliance-heavy SAM: 400 fleet/construction/staffing employers x 60 covered workers x 1.5 tests per worker x $65 blended = about $2.34M.

SOM

• A defensible first-five-year SOM for a small buyer is 3-8% of local SAM if the company has direct employer relationships and reliable turnaround.
• On the $2.34M compliance-heavy SAM above, 5% share is $117K revenue; 15% share is $351K. That is why acquisitions beat startups here: existing account density matters.
• A strong local platform can reach $750K-$2M revenue by combining clinic volume, mobile collections, DOT administration, and occupational-health add-ons.

3) Moat Analysis

• Compliance process: chain-of-custody accuracy, collector training, documented procedures, and audit readiness create real switching friction.
• Employer account trust: HR and safety managers hate vendor changes once testing is reliable. Speed and zero-drama reporting matter more than brand polish.
• Lab and MRO relationships: established pricing, portals, reporting workflows, and turnaround expectations reduce operational friction.
• Route density and mobile coverage: mobile collections turn urgent jobs into premium-priced revenue and make the operator harder to replace for fleets and job sites.
• Data hygiene: a clean roster of covered employees, random pool schedules, test history, policy documents, and contact workflows is a small but durable moat.
• Weak moat if: the business is just a walk-in collection site with no employer contracts, no recurring cadence, no mobile capability, and no proprietary account relationships.

4) Unit Economics (3 concrete scenarios with numbers)

Scenario A — Small collection clinic, mostly pre-employment

• Monthly volume: 450 tests at $58 average revenue = $26,100.
• Direct lab/MRO/test-kit cost: $20 per test = $9,000.
• Gross profit: $17,100, or 66% gross margin.
• Fixed monthly overhead: collector/admin payroll $7,500, rent $2,200, software/portal $600, insurance $400, marketing/admin $900.
• Monthly SDE before owner replacement: $5,500; annualized SDE: $66,000.
• Acquisition view: at 3.0x SDE, price is about $198K. This only works if the buyer can either operate directly or prove replacement labor is already included.

Scenario B — Employer account base plus DOT consortium administration

• 75 employer accounts averaging 18 tests/year at $65 = $87,750 annual test revenue.
• 600 covered drivers/workers paying $120/year admin fee = $72,000 annual recurring admin revenue.
• Mobile/on-site fees: 220 visits/year at $95 net service fee = $20,900.
• Total revenue: $180,650.
• Direct costs: tests/lab/MRO at 34% of test revenue = $29,835; mobile labor/fuel $9,000; software/compliance $8,400; admin payroll $48,000; rent/insurance/misc $18,000.
• Annual SDE: about $67,400, or 37% before owner sales time; normalize to $45K-$55K if the owner is doing heavy unpaid account management.
• Acquisition view: pay 3.0x-3.8x normalized SDE only if accounts transfer cleanly and random-pool data is organized.

Scenario C — Mature local platform with mobile industrial accounts

• Revenue mix: 9,000 annual tests at $62 = $558,000; DOT/admin fees $140,000; mobile and after-hours fees $125,000; occupational-health add-ons $175,000.
• Total revenue: $998,000.
• Direct testing/lab/kit/MRO cost at 32% of test revenue = $178,560.
• Field collectors and admin payroll: $310,000.
• Rent, vehicles, fuel, insurance, software, sales, training, and G&A: $255,000.
• EBITDA/SDE: about $254,000, or 25% margin.
• Acquisition view: 4.0x SDE implies about $1.02M enterprise value. With 10% seller note and 10% holdback, a buyer reduces transfer risk and preserves cash for working capital.

5) Due Diligence Checklist

• Pull 36 months of P&L, tax returns, bank statements, merchant deposits, customer-level revenue, and test volume by type.
• Separate revenue into pre-employment, random, post-accident, DOT consortium/admin, mobile collections, alcohol testing, and occupational-health add-ons.
• Rebuild gross margin by test type: price charged, lab/MRO cost, supplies, collector time, travel time, failed/no-show appointments, and redraw/retest rates.
• Verify top 20 customers: contract terms, renewal dates, pricing, volume, decision-maker, transferability, and last 12-month test count.
• Review lab agreements, MRO agreements, collector certifications/training, software subscriptions, privacy/security practices, and complaint history.
• Audit chain-of-custody samples from intake to result delivery. One sloppy file is a process issue; many sloppy files are a deal problem.
• Confirm DOT program handling: random pool generation, selection notices, completion tracking, annual MIS reporting support, return-to-duty process, and record retention.
• Validate mobile economics by riding along: travel time, cancellations, site access, wait time, after-hours premiums, and collector utilization.
• Check insurance coverage, leases, vehicle titles/leases, equipment list, open claims, state licensing rules, and any medical director/clinical oversight requirements.
• Call 10 customers before close, with seller permission, to verify satisfaction, why they use the company, and whether they would stay after transition.

6) What to Watch For

• Marijuana policy changes can reduce pre-employment volume in some roles, but safety-sensitive, DOT, post-accident, and reasonable-suspicion testing remain durable.
• Top-customer concentration above 25-30% of revenue should lower the multiple or require earnout/retention protection.
• Lab turnaround problems can look like vendor issues but cause customer churn at the local operator level.
• Owner-dependent sales is common. If the owner personally knows every HR manager and nothing is in the CRM, assume transition risk.
• Low advertised test prices may exclude MRO, confirmation testing, collection fees, or admin work. Underwrite actual gross profit, not menu price.
• Privacy, documentation, and chain-of-custody failures can create legal exposure and destroy trust fast.
• No-shows and same-day cancellations quietly kill utilization, especially for mobile collectors.

7) How to Finance the Acquisition

• SBA 7(a): viable when cash flow is documented, buyer has enough operating competence, and the business is not dependent on unverifiable cash or one customer.
• Seller financing: ask for 10-25% of purchase price on a 3-5 year note. This aligns the seller around account transition and documentation quality.
• Retention holdback: hold back 5-15% of price for 90-180 days tied to retained revenue from named employer accounts.
• Earnout: useful when the seller claims growth from large employer accounts that are not yet proven. Pay only as revenue materializes.
• Working capital: reserve 1-2 months of payroll, lab payables, supplies, software, insurance, and vehicle costs. A $750K-revenue operator can need $60K-$120K liquidity.
• Do not overfinance equipment: most value is in relationships and process, not chairs, cups, and office furniture. Vehicles and lab equipment should be valued conservatively.

8) Valuation & Deal Structure Cheatsheet

• Tiny owner-operated collection site: 2.0x-3.0x normalized SDE if customer records are weak or owner replacement is not included.
• Documented employer-account business: 3.0x-4.0x SDE with transferable accounts, clean gross-margin data, and low concentration.
• Scaled local platform: 4.0x-5.0x SDE/EBITDA if revenue is diversified, mobile routes are dense, admin fees recur, and the management team can run without the seller.
• Discounts: subtract for weak chain-of-custody files, no contracts, top-customer concentration, expiring lease, no CRM, thin collector bench, or pending compliance disputes.
• Premiums: pay more for written employer contracts, recurring DOT/admin fees, dense mobile routes, low churn, clean systems, and occupational-health cross-sell.
• Preferred structure: 75-85% cash at close, 10-20% seller note, 5-10% retention holdback, plus a working-capital target based on normal payroll and lab payables.
• Debt test: post-close cash flow should cover debt service by at least 1.25x after paying a real operator salary and reserving for working capital.

9) 10 Questions to Ask the Owner

1. What percentage of revenue is pre-employment, random, DOT, post-accident, mobile, admin fees, and occupational-health add-ons?
2. Who are the top 20 customers, how long have they been customers, and what revenue did each generate in the last 12 months?
3. Are customer relationships under written contract, master service agreement, portal setup, or handshake?
4. What is the average price and gross profit per test type after lab, MRO, supplies, labor, and travel time?
5. How are chain-of-custody records stored, audited, and corrected when errors occur?
6. Which labs, MROs, and software platforms are used, and can those agreements transfer to a buyer?
7. How many active collectors are trained, what can each perform, and who covers after-hours/post-accident calls?
8. What customer churn occurred in the last 24 months and why?
9. What compliance issue, complaint, audit finding, or legal dispute has happened in the last five years?
10. If you disappeared for 30 days, which customers, processes, or sales activities would break first?

10) 7-Day Action Plan

1. Build a local target list of drug testing clinics, occupational-health sites, mobile collectors, and DOT consortium administrators within 60 miles.
2. Pull every public review and classify complaints by speed, professionalism, documentation, hours, and result turnaround.
3. Call as a mystery-shopper employer and request pricing for 20 pre-employment screens, random DOT pool setup, and one on-site collection day.
4. Create a one-page underwriting template with test volume, gross profit per test, admin-fee revenue, mobile utilization, top-customer concentration, and replacement labor.
5. Contact 20 owners with a direct acquisition note focused on continuity, confidentiality, and protecting employer relationships.
6. For any seller reply, request customer-level revenue, test volume by type, lab/MRO costs, software stack, and top-10 account concentration before discussing price.
7. Issue an LOI only if the deal clears three gates: less than 25% top-customer concentration, clean chain-of-custody samples, and at least 1.25x debt-service coverage after owner replacement.

BizBite Deep Dive | July 6, 2026 | Workplace Drug Testing Services